ClinicalTrials.gg
Not yet recruitingNCT06557200Updated Aug 16, 2024

A Virtual Support Intervention for Postnatal Well-being

An interventional study of Digital Infant- parents support in Postnatal Depression and Mother-Infant Interaction, sponsored by Universiti Putra Malaysia. Not yet recruiting at 1 site in Pakistan. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-16.

Sponsored by Universiti Putra Malaysia · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2025, 1 year 4 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
1,400
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 12 studies in Depression, Postpartum with a site in Pakistan — 2 open to participants now, 2 under way, none of them phase 3. Depression, Postpartum · Pakistan.

Planned enrollment
2nd of 12
1,400 · median 107
Started
2024
the only one that year
No phase
10 of 12
2 open now
Registered
12th of 12
by date
Lead sponsor
1 of 12
Universiti Putra Malaysia

Among the 12 studies in Depression, Postpartum with a site in Pakistan, this one is the 2nd largest by planned enrollment, is the only one that started in 2024, is one of 10 with no phase, and was the 12th registered.

Depression, Postpartum

570 studies on the registry are indexed under Depression, Postpartum; 135 are open to participants now.

Browse Depression, Postpartum studies →

Open to participants now

2 of the 12 studies in Depression, Postpartum with a site in Pakistan are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →

Who these studies take

Of the 88 Depression, Postpartum studies recruiting now, 54 (61%) set no upper age limit and 31 (35%) stop at 75 or younger; 13 take children under 18; 40 take healthy volunteers.

This study: 18 Years to 45 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Depression, Postpartum with a site in Pakistan, or all of them as a file.
02

Study summary

Postnatal depression (PND) and anxiety are significant public health concerns affecting a substantial proportion of new mothers worldwide. These conditions can have profound consequences for both maternal and infant well-being, including increased risk of

  1. maternal morbidity
  2. impaired parent-infant bonding
  3. long-term developmental challenges for the child.
Read the detailed description

Despite the prevalence and impact of PND and anxiety, access to timely and effective mental health care for postpartum women remains limited, particularly in resource-constrained settings.

Limited Research: There has been a historical underinvestment in mental health research in Pakistan, especially in maternal mental health.

Cultural Stigma: Mental health issues, particularly postpartum depression, are often stigmatized, leading to underreporting.

Data Infrastructure: Robust data collection and analysis systems for mental health are still developing in Pakistan The rationale for this study is grounded in the significant public health burden imposed by postnatal depression (PND) and anxiety, coupled with the limitations of traditional care models. Despite advancements in maternal and child health, postpartum mental health remains a neglected area in many countries, including Pakistan.

03

Conditions studied

  • Postnatal Depression
  • Mother-Infant Interaction
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pakistani female aged 18-45 years
  • Recent childbirth (within 0-6 weeks)
  • Access to a smartphone or computer with internet connectivity
  • Able to understand and communicate in Urdu or English
  • Willing to provide

Exclusion criteria

Exclusion Criteria:

  • Pre-existing severe mental illness (e.g., schizophrenia, bipolar disorder)
  • Current substance abuse or dependence
  • Limited or no access to the internet or smartphone
  • Inability to understand or communicate in Urdu or English
  • Pregnancy complications requiring intensive care
  • Infants with severe medical conditions requiring hospitalization
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
1,400 participants (estimated)

Study arms

  • Experimental
    Intervention group

    A virtual and in-person, personal and group-based intervention will be delivered-educational information on infant behavior and changes in interpersonal dynamics associated with parenting. Modules aimed at understanding and managing infant behavior include information on infant temperament. Personal support will be provided by face-to-face education and WhatsApp messages and videos. Group support will be provided by mothers and their partners or a support person group discussion.

    Behavioral: Digital Infant- parents support

  • No intervention
    Control

    No intervention will be provided except usual care

Interventions

  • BehavioralDigital Infant- parents support

    A virtual and in-person, personal and group-based intervention will be delivered-educational information on infant behavior and changes in interpersonal dynamics associated with parenting. Modules aimed at understanding and managing infant behavior include information on infant temperament. Personal support will be provided by face-to-face education and WhatsApp messages and videos. Group support will be provided by mothers and their partners or a support person group discussion.

06

What researchers measure

Primary outcomes

  1. Post natal depression

    Edinburgh Postnatal Depression Scale (EPDS): A standardized self-report questionnaire to assess symptoms of postnatal depression. Scores are between 0 and 30, with scores 13 and above indicating depressive illness, or a high risk of developing a depressive disorder. Scores of 13 indicate an 80% chance that the mother has depression.

    Time frame: Post natal Depression measured at baseline and 12 months

  2. Post natal anxiety

    Generalized Anxiety Disorder-7 (GAD-7): A self-report measure to assess symptoms of generalized anxiety disorder. The GAD-7 scores were also represented with clinical categorizations of anxiety levels as follows: GAD-7 score of 0-4 (none), 5-9 (mild), 10-14 (moderate), and 15-21 (severe).

    Time frame: Post natal Anxiety measured at baseline and 12 months

  3. Intervention usage

    Intervention usage will be assessed by tracking participants' engagement with the online platform, including login frequency, module completion, and time spent on the platform.

    Time frame: Intervention usage measured at 12 months

07

Study locations

1 site
  • Ahmad Hospital
    Lahore, Punjab 54590, Pakistan
08

References and documents

Publications

  • Woody CA, Ferrari AJ, Siskind DJ, Whiteford HA, Harris MG. A systematic review and meta-regression of the prevalence and incidence of perinatal depression. J Affect Disord. 2017 Sep;219:86-92. doi: 10.1016/j.jad.2017.05.003. Epub 2017 May 8. PubMed 28531848 ↗
  • Hahn-Holbrook J, Cornwell-Hinrichs T, Anaya I. Economic and Health Predictors of National Postpartum Depression Prevalence: A Systematic Review, Meta-analysis, and Meta-Regression of 291 Studies from 56 Countries. Front Psychiatry. 2018 Feb 1;8:248. doi: 10.3389/fpsyt.2017.00248. eCollection 2017. PubMed 29449816 ↗
  • Coo S, Garcia MI, Mira A, Valdes V. The Role of Perinatal Anxiety and Depression in Breastfeeding Practices. Breastfeed Med. 2020 Aug;15(8):495-500. doi: 10.1089/bfm.2020.0091. Epub 2020 Jun 9. PubMed 32522015 ↗
  • Rojas G. Análisis de La Situación de Uso de Servicios y Acceso a Tratamiento de La Depresión Posparto En Centros APS de La Región Metropolitana. Santiago, Chile: Universidad de Chile, http://www.crececontigo.gob.cl/wp-content/uploads/2015/11/5-Informe-Final-Analisis-de-lasituacion-de-uso-de-servicio-y-acceso-a-tratamiento-de-la-depresion-posparto.pdf (2013, accessed 15 January 2022).
  • Priel A, Djalovski A, Zagoory-Sharon O, Feldman R. Maternal depression impacts child psychopathology across the first decade of life: Oxytocin and synchrony as markers of resilience. J Child Psychol Psychiatry. 2019 Jan;60(1):30-42. doi: 10.1111/jcpp.12880. Epub 2018 Feb 27. PubMed 29484656 ↗

Individual participant data

Plan to share: No — Study protocol, Statistical plan, Results will be desseminated through publications

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Aug 2024; primary completion for Jul 2025, 11 months later.

Of 259 non-industry interventional studies with no phase under Depression, Postpartum, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 35. This study's planned 11 months is below that.

Counting every sponsor, half of 265 studies reached it within 23 months; a quarter within 11 and three quarters within 35.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 13, 2024
First posted
Aug 16, 2024
StartEst.
Aug 15, 2024
Primary completionEst.
Jul 15, 2025
CompletionEst.
Aug 10, 2025
Last update
Aug 16, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 16, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06557200
Responsible party
Arshed Muhammad (PhD studentship, Universiti Putra Malaysia) — Principal investigator
First posted
Aug 16, 2024
Start date
Aug 15, 2024 (estimated)
Primary completion
Jul 15, 2025 (estimated)
Completion
Aug 10, 2025 (estimated)
Last update
Aug 16, 2024

Study contacts

Raashed Muhammad, Master
Contact
stunning003@gmail.com
03249479263

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion